Berberine

Plant alkaloid with meta-analysis support for modest improvements in glucose measures, used with care.

Evidence
Preliminary evidenceGRADE certainty: Low
Typical dose
500 mg two or three times daily before meals
Time to effect
Glycemic effects emerge over 2–4 weeks
Safety
Has documented cautions

Evidence ratings summarise published research on Berberine in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.

Ask about Berberine

Interactions

Taking any medication?

Check Berberine against it.

Why

Berberine is an isoquinoline alkaloid found in several botanicals (Berberis aristata, Coptis chinensis, goldenseal). A meta-analysis of 20 RCTs (n=1,761) found it lowered fasting glucose, HbA1c and HOMA-IR versus placebo, with larger fasting glucose reductions in women, people with diabetes and Asians. The authors call the effects modest, and certainty is low. Trials compared berberine with placebo, not with metformin or statins. The molecule has meaningful pharmacology, not a casual supplement.

How it works

Activates AMP-activated protein kinase (AMPK). Modulates gut microbiota composition (Akkermansia, Bacteroides) which appears to contribute to the metabolic effect.

Expected onset · Glycemic effects emerge over 2–4 weeks

How to take

Dosage

500 mg two or three times daily before meals (1,000–1,500 mg/day total).

Timing

30 minutes before meals

On the label

Look for 'berberine HCl' with stated milligrams. Plant extracts (goldenseal, Berberis) vary widely; standardised berberine HCl is the form used in clinical trials.

Studied in

Adults with prediabetes or type 2 diabetes interested in a botanical option with modest glucose-lowering data, best with clinical supervision when overlapping with prescribed medications.

Safety

Pharmacologically active, treat as a medication, not a casual supplement. Common GI side effects (constipation, cramping, diarrhoea); trials often started at a low dose and increased gradually. Strong CYP3A4 and CYP2D6 inhibition: substantial interaction risk with statins (especially simvastatin), ciclosporin, warfarin, midazolam, and many cardiovascular drugs. Hypoglycaemia risk if combined with insulin or sulphonylureas. Avoid in pregnancy (kernicterus risk in neonates), breastfeeding, and severe liver disease.
Loading interactions…

Evidence

At a glance

Zhao 2023 J Nutr meta-analysis of 20 RCTs (n=1,761): berberine lowered fasting glucose by 0.52 mmol/L, HbA1c by 4.48 mmol/mol and HOMA-IR by 0.85 versus placebo, with larger fasting glucose reductions in women, people with diabetes and Asians (subgroup comparisons rest on few studies). The trials compared berberine with placebo, not with metformin or statins.

GRADE certainty: Low — rated by Healicus using the GRADE method

Questions people ask

Does Berberine work?

Zhao 2023 J Nutr meta-analysis of 20 RCTs (n=1,761): berberine lowered fasting glucose by 0.52 mmol/L, HbA1c by 4.48 mmol/mol and HOMA-IR by 0.85 versus placebo, with larger fasting glucose reductions in women, people with diabetes and Asians (subgroup comparisons rest on few studies). The trials compared berberine with placebo, not with metformin or statins. Certainty of the evidence: Low, rated by Healicus using the GRADE method.

How is Berberine taken?

500 mg two or three times daily before meals (1,000–1,500 mg/day total). Timing: 30 minutes before meals. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.

Are there interactions or cautions?

Pharmacologically active, treat as a medication, not a casual supplement. Common GI side effects (constipation, cramping, diarrhoea); trials often started at a low dose and increased gradually. Strong CYP3A4 and CYP2D6 inhibition: substantial interaction risk with statins (especially simvastatin), ciclosporin, warfarin, midazolam, and many cardiovascular drugs. Hypoglycaemia risk if combined with insulin or sulphonylureas. Avoid in pregnancy (kernicterus risk in neonates), breastfeeding, and severe liver disease. Documented drug and supplement interactions can be looked up in the free interaction reference.

What is the evidence based on?

Sources: Zhao JV et al., Overall and Sex-Specific Effect of Berberine on Glycemic and Insulin-Related Traits: a Systematic Review and Meta-Analysis of Randomized Controlled Trials, J Nutr 2023.

One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.